Engagement with Interventional Radiologists Reaches Highest Level Yet as Company Continues to Progress Through Regulatory and Clinical Phases; Company Seeking...
MEDFORD, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious...
The leading virtual Opioid Use Disorder treatment provider will fill gaps in care for formerly incarcerated patients struggling with opioid...
WAKEFIELD, MA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical...
Company Focuses on Development of Neuromuscular Blocking Agents Phase II Randomized Trial for BX1000 Initiated, Positive Interim Results Announced; Completion...
CHCM Will Conduct the Ultimate Competency Assessment WorkshopAtlanta, GA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- From March 14 to 17,...
Topline Data from ZETA-1 Phase 2 Trial of Oral APX3330 in Diabetic Retinopathy Presented on February 11th at 20th Angiogenesis,...
Record full-year 2022 total preliminary unaudited revenue of €55.1 million ($58.0 million) represents an increase of 25.1% over full-year 2021,...
NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company...
KKR-backed Replay and MD Anderson form new product company Syena to pioneer first-in-class TCR-NK cell therapy Cord blood-derived T-Cell Receptor...
Latest Swoop® software improves image quality for DWI imaging of the brainGUILFORD, Conn., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Hyperfine,...
VANCOUVER, British Columbia, Feb. 13, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH)...
Cardiac interventional suite at TriHealth Heart & Vascular Institute on the campus at Bethesda North Exam room in the cardiac...
Top rankings in Ambulatory RCM Services, Robotic Process Automation and Denials Management Services underscore expertise and ability to deliver complete...
Collaboration will establish a platform cGMP line to support Elektrofi’s planned clinical trials of injectable biologicsBOSTON, Feb. 07, 2023 (GLOBE...
Figure 1 Proposed KETARX™ on-body kit and application. Not FDA approved. Not for sale.TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) --...
TORONTO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX:VHIBF) is pleased to announce...
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that its Biologics License Application (BLA) for...
TORONTO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) was pleased to begin the new...
SALT LAKE CITY, UT, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. (Nasdaq: UTMD) finished...